Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude?


Journal

Respiratory physiology & neurobiology
ISSN: 1878-1519
Titre abrégé: Respir Physiol Neurobiol
Pays: Netherlands
ID NLM: 101140022

Informations de publication

Date de publication:
06 2020
Historique:
received: 12 04 2020
accepted: 13 04 2020
pubmed: 26 4 2020
medline: 14 5 2020
entrez: 26 4 2020
Statut: ppublish

Résumé

In the present study we analyze the epidemiological data of COVID-19 of Tibet and high-altitude regions of Bolivia and Ecuador, and compare to lowland data, to test the hypothesis that high-altitude inhabitants (+2,500 m above sea-level) are less susceptible to develop severe adverse effects in acute SARS-CoV-2 virus infection. Analysis of available epidemiological data suggest that physiological acclimatization/adaptation that counterbalance the hypoxic environment in high-altitude may protect from severe impact of acute SARS-CoV-2 virus infection. Potential underlying mechanisms such as: (i) a compromised half-live of the virus caused by the high-altitude environment, and (ii) a hypoxia mediated down regulation of angiotensin-converting enzyme 2 (ACE2), which is the main binding target of SARS-CoV-2 virus in the pulmonary epithelium are discussed.

Identifiants

pubmed: 32333993
pii: S1569-9048(20)30101-4
doi: 10.1016/j.resp.2020.103443
pmc: PMC7175867
pii:
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103443

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Références

Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
J Ethnopharmacol. 2020 Mar 25;250:112470
pubmed: 31862407
Int J Mol Sci. 2017 Jul 13;18(7):
pubmed: 28703764
Chin Med J (Engl). 2020 May 5;133(9):1015-1024
pubmed: 32004165
High Alt Med Biol. 2001 Winter;2(4):489-99
pubmed: 11809089
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
J Physiol. 2007 Jan 1;578(Pt 1):309-14
pubmed: 17095558
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Physiol Res. 2015;64(1):25-38
pubmed: 25194138
Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L631-40
pubmed: 19592460
Sci Data. 2020 Mar 24;7(1):106
pubmed: 32210236
J Physiol. 2005 Oct 15;568(Pt 2):559-71
pubmed: 16051624
J Virol. 2005 Dec;79(23):14614-21
pubmed: 16282461
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14009-14
pubmed: 9826643

Auteurs

Christian Arias-Reyes (C)

Institute Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Faculty of Medicine, Université Laval, Québec, QC, Canada.

Natalia Zubieta-DeUrioste (N)

High Altitude Pulmonary and Pathology Institute IPPA. La Paz, Bolivia.

Liliana Poma-Machicao (L)

Institute Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Faculty of Medicine, Université Laval, Québec, QC, Canada.

Fernanda Aliaga-Raduan (F)

Institute Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Faculty of Medicine, Université Laval, Québec, QC, Canada.

Favio Carvajal-Rodriguez (F)

Institute Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Faculty of Medicine, Université Laval, Québec, QC, Canada.

Mathias Dutschmann (M)

Florey Institute of Neuroscience and Mental Health, Gate 11 Royal Parade, 3052, University of Melbourne Victoria, Australia.

Edith M Schneider-Gasser (EM)

Institute of Veterinary Physiology, Vetsuisse-Faculty University of Zurich, Winterthurerstrasse 260, Switzerland.

Gustavo Zubieta-Calleja (G)

High Altitude Pulmonary and Pathology Institute IPPA. La Paz, Bolivia. Electronic address: gzubietajr@gmail.com.

Jorge Soliz (J)

Institute Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Faculty of Medicine, Université Laval, Québec, QC, Canada; High Altitude Pulmonary and Pathology Institute IPPA. La Paz, Bolivia. Electronic address: jorge.soliz@crchuq.ulaval.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH